Scope and Content
Title: McNaughton Foundation Publications, Correspondence,
Date (inclusive): 1967-1975
Collection number: MSS 78-7
Extent: 1 carton
University of California, San Francisco. Library. Archives and Special Collections.
San Francisco, California 94143-0840
Shelf location: For current information on the location of these
materials, please consult the Library's online catalog.
These materials were received in February 1978 with the Chauncey D. Leake papers (MSS
Collection is open for research.
[Identification of item], McNaughton Foundation publications, correspondence, MSS 78-7,
Archives & Special Collections, UCSF Library & CKM
The McNaughton Foundation is a non-profit organization which sponsors scientific research
and which "seeks to encourage the creative scientific atmosphere in which the researcher
follows his own lines of investigation toward the solution of his problem, even if these
lines are in opposition to prevailing scientific or political opinion." Its director,
Andrew R. L. McNaughton, is a general consultant specializing in international affairs.
The foundation sponsors research projects dealing with mental health, the aging process,
cancer, heart disease and diabetes. An advisory board, made up of distinguished
scientists from Europe and North America, advises the foundation's director in the
disposition of funding and identification of projects worthy of support. Of interest in
this regard is the presence of Dr. Ernst T. Krebs, Jr., on the advisory board; he is
listed as a board member in documents (found in folder 2) from 1968 and 1975. The 1975
document states: "Dr. Krebs is a discoverer of Vitamins B-15 and B-17 and a number of
other substances whose development the foundation is sponsoring."
The McNaughton Foundation was originally based in Montreal, Quebec, Canada, but at some
point in the late 1960s it appears to have opened offices in California. An associated
organization, the Jacqueline Magella McNaughton Memorial Trust, sponsors investigational
work in the area of parapsychology.
Scope and Content
The bulk of these records consists of reports and other documents created between 1968
and 1970 relative to Laetrile (amygdalin) and its application in treatment and prevention
of cancer. Of the publications itemized below, writings by Dr. Ernst T. Krebs, Jr. appear
in items 2, 3, 5, 13 and 14; references to Dr. Krebs or his work appear in items 1, 4, 10